2 Clinical Trials Of Experimental Ebola Vaccines Begin In Europe, Africa
Reuters: Two new trials of Ebola vaccines begin in Europe and Africa
“Two new Ebola vaccine trials began on Wednesday with volunteers in Britain, France, and Senegal getting ‘prime-boost’ immunizations developed by Bavarian Nordic, GlaxoSmithKline, and Johnson & Johnson…” (Kelland, 7/15).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.